The National Medical Stores (NMS) has received a significant shipment of 500,000 doses of the Hepatitis B vaccine, funded by the government of Uganda.

The Hepatitis B vaccine is a crucial tool in preventing the spread of this serious liver infection, which can lead to chronic liver disease, liver cancer, and even death.

In a statement released by the National Medical Stores (NMS) official handle, X, on October 22, 2024, it confirmed to have received half a million doses of the Hepatitis B vaccine bought with funding from the government of Uganda.

“We are pleased to inform all Ugandans that NMS has received half a million doses of the Hepatitis B vaccine bought with funding from the government of Uganda,’’ part of the statement read.

Read Also: Medical Expert Warns Hepatitis B Patients Against Using Herbs

The statement further noted that the consignment will soon be distributed to health facilities across the country to enhance immunization efforts against the viral infection that affects millions worldwide.

According to the World Health Organization (WHO) report, in 2022, an estimated 1,250 Ugandans died of the disease, and around 6% of Uganda’s population remains chronically infected.

Uganda’s Ministry of Health, with technical support from WHO, subsequently developed a strategy to control hepatitis B, including public awareness raising, testing, and treatment nationwide.

With over four million people screened to date, and more than 30% of people infected with hepatitis B are aware of their status and can access comprehensive treatment services, including free medication.

In a report by the World Health Organization Around 90% of all infants receive childhood vaccinations, making Uganda the first country in Africa to reach and surpass WHO’s 2020 program targets of diagnosing 30% of people living with hepatitis B, ensuring awareness of and access to care.